Resultados globales: 3 registros encontrados en 0.02 segundos.
Artículos, Encontrados 3 registros
Artículos Encontrados 3 registros  
1.
13 p, 1.5 MB Inspecting the Ribozyme Region of Hepatitis Delta Virus Genotype 1 : Conservation and Variability / Pacín Ruiz, Beatriz (Hospital Universitari Vall d'Hebron) ; Cortese, Maria Francesca (Hospital Universitari Vall d'Hebron) ; Tabernero, David (Hospital Universitari Vall d'Hebron) ; Sopena, Sara (Hospital Universitari Vall d'Hebron) ; Gregori i Font, Josep (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; García-García, Selene (Hospital Universitari Vall d'Hebron) ; Casillas, Rosario (Hospital Universitari Vall d'Hebron) ; Najarro-Centeno, Adrián (Hospital Universitari Vall d'Hebron) ; Aldama, Unai (Hospital Universitari Vall d'Hebron) ; Palom, Adriana (Hospital Universitari Vall d'Hebron) ; Rando-Segura, Ariadna (Hospital Universitari Vall d'Hebron) ; Galán, Anna (Hospital Universitari Vall d'Hebron) ; Vila, Marta (Hospital Universitari Vall d'Hebron) ; Riveiro Barciela, Mar (Hospital Universitari Vall d'Hebron) ; Quer, Josep 1963- (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; González-Aseguinolaza, Gloria (Univerdad de Pamplona) ; Buti, Maria (Hospital Universitari Vall d'Hebron) ; Rodríguez Frías, Francisco (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
The hepatitis delta virus (HDV) genome has an autocatalytic region called the ribozyme, which is essential for viral replication. The aim of this study was to use next-generation sequencing (NGS) to analyze the ribozyme quasispecies (QS) in order to study its evolution and identify highly conserved regions potentially suitable for a gene-silencing strategy. [...]
2022 - 10.3390/v14020215
Viruses, Vol. 14 (january 2022)  
2.
16 p, 2.1 MB Cationic liposome- multi-walled carbon nanotubes hybrids for dual siPLK1 and doxorubicin delivery in vitro / Pereira, Sara (University of East Anglia. School of Pharmacy) ; Lee, Jin (King's College London. Institute of Pharmaceutical Science) ; Rubio, Noelia (King's College London. Institute of Pharmaceutical Science) ; Hassan, Hatem A. F. M. (King's College London. Institute of Pharmaceutical Science) ; Suffian, Izzat Bin Mohamed (King's College London. Institute of Pharmaceutical Science) ; Wang, Julie T. W. (King's College London. Institute of Pharmaceutical Science) ; Klippstein, Rebecca (King's College London. Institute of Pharmaceutical Science) ; Ballesteros, Belén (Institut Català de Nanociència i Nanotecnologia) ; Al-Jamal, Wafa' T. (University of East Anglia. School of Pharmacy) ; Al-Jamal, Khuloud T. (King's College London. Institute of Pharmaceutical Science)
To formulate f -MWNTs-cationic liposome hybrids for the simultaneous delivery of siPLK1 and doxorubicin to cancer cells. f -MWNTs-cationic liposome hybrids were prepared by the thin film hydration method where the lipid film was hydrated with 100 μg/ml or 1 mg/ml of ox-MWNTs-NH₃+ or MWNTs-NH₃+ in 5% dextrose. [...]
2015 - 10.1007/s11095-015-1707-1
Pharmaceutical research, Vol. 32, Issue 10 (Oct. 2015) , p. 3293-3308  
3.
20 p, 10.3 MB PKM2 subcellular localization is involved in oxaliplatin resistance acquisition in HT29 human colorectal cancer cell lines / Ginés Molina, Alba (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Bystrup, Sara (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ruiz de Porras, Vicenç (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Guardia, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Musulén, Eva (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Martínez Cardús, Anna (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Manzano, José Luis (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Layos, Laura (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Abad, Albert (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Martínez Balibrea, Eva (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Chemoresistance is the main cause of treatment failure in advanced colorectal cancer (CRC). However, molecular mechanisms underlying this phenomenon remain to be elucidated. In a previous work we identified low levels of PKM2 as a putative oxaliplatin-resistance marker in HT29 CRC cell lines and also in patients. [...]
2015 - 10.1371/journal.pone.0123830
PloS one, Vol. 10, No. 5 (May 2015) , p. e0123830  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.